Hexal MetoHEXAL Succ 95 mg

MetoHEXAL is a widely utilized medication in Germany for treating hypertension and other cardiovascular conditions. It contains metoprolol succinate as its active ingredient. The brand name Hexal is a prominent generic pharmaceutical label founded in Germany during the 1980s.

Starting as a family-run enterprise, Hexal grew to become one of the leaders in the German generic drug market. In 2005, it was acquired by the Swiss pharmaceutical giant Novartis. Today, Hexal is an integral part of Sandoz, which was spun off from Novartis in 2023 to become an independent, publicly traded global leader in generic and biosimilar medicines. While the brand maintains its headquarters and primary manufacturing focus in Germany, it operates under the global umbrella of Sandoz, headquartered in Switzerland.